Basic fibroblast growth factor modulates cell cycle of human umbilical cord-derived mesenchymal stem cells

Cell Proliferation

Volumn 45, Issue 2, 2012, Pages 132-139

  Ramasamy, R ^a   Tong, C K ^a   Yip, W K ^a   Vellasamy, S ^a   Tan, B C ^b   Seow, H F ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b Britannia Women and Children Specialist Centre   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D; FIBROBLAST GROWTH FACTOR 2;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE CHECKPOINT; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CULTURE OPTIMIZATION; CYTOKINE RELEASE; DNA SYNTHESIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN UMBILICAL CORD MESENCHYMAL STEM CELL; IMMUNOMODULATION; MESENCHYMAL STEM CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STEM CELL EXPANSION;

APOPTOSIS; CELL COMMUNICATION; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINES; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; MATRIX METALLOPROTEINASE 3; MESENCHYMAL STEM CELLS; PREGNANCY; T-LYMPHOCYTES; UMBILICAL CORD; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84857626110     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2012.00808.x     Document Type: Article

References (35)

1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147.
2. Sukhikh GT, Malaitsev VV, Bogdanova IM, Dubrovina IV (2002) Mesenchymal stem cells. Bull. Exp. Biol. Med. 133, 103-109.
3. Erices A, Conget P, Minguell JJ (2000) Mesenchymal progenitor cells in human umbilical cord blood. Br. J. Haematol. 109, 235-242.
4. Tong CK, Vellasamy S, Chong Tan B, Abdullah M, Vidyadaran S, Fong Seow H et al. (2011) Generation of mesenchymal stem cell from human umbilical cord tissue using a combination enzymatic and mechanical disassociation method. Cell Biol. Int. 35, 221-226.
5. Dazzi F, Ramasamy R, Glennie S, Jones S, Roberts I (2005) The role of mesenchymal stem cells in haemopoiesis. Blood Rev. 20(16), 1-171.
6. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M et al. (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363, 1439-1441.
7. Maqbool M, Vidyadaran S, George E, Ramasamy R (2011) Human mesenchymal stem cells protect neutrophils from serum-deprived cell death. Cell Biol. Int. 35, 1247-1251.
8. Sarmadi VH, Tong CK, Vidyadaracn S, Abdullah M, Seow HF, Ramasamy R (2010) Mesenchymal stem cells inhibit proliferation of lymphoid origin haematopoietic tumour cells by inducing cell cycle arrest. Med. J. MYS 65, 209-214.
9. Hamada H, Kobune M, Nakamura K, Kawano Y, Kato K, Honmou O et al. (2005) Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy. Cancer Sci. 96, 149-156.
10. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M et al. (1999) Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med. 5, 309-313.
11. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH (2004) Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103, 1669-1675.
12. Tondreau T, Meuleman N, Delforge A, Dejeneffe M, Leroy R, Massy M et al. (2005) Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells 23, 1105-1112.
13. Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, Merchav S et al. (2006) Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 24, 781-792.
14. Ilancheran S, Moodley Y, Manuelpillai U (2009) Human fetal membranes: a source of stem cells for tissue regeneration and repair? Placenta 30, 2-10.
15. Prather WR, Toren A, Meiron M (2008) Placental-derived and expanded mesenchymal stromal cells (PLX-I) to enhance the engraftment of hematopoietic stem cells derived from umbilical cord blood. Expert Opin. Biol. Ther. 8, 1241-1250.
16. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C et al. (2002) Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100, 1611-1618.
17. Secco M, Zucconi E, Vieira NM, Fogaca LL, Cerqueira A, Carvalho MD et al. (2008) Multipotent stem cells from umbilical cord: cord is richer than blood. Stem Cells 26, 146-150.
18. Romanov YA, Svintsitskaya VA, Smirnov VN (2003) Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 21, 105-110.
19. Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE (2005) Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 23, 220-229.
20. Barda-Saad M, Zhang AS, Zipori D, Rozenszajn LA (1997) Adhesion of thymocytes to bone marrow stromal cells: regulation by bFGF and IFN-gamma. Stem Cells 15, 229-236.
21. Hanada K, Dennis JE, Caplan AI (1997) Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J. Bone Miner. Res. 12, 1606-1614.
22. Hori Y, Inoue S, Hirano Y, Tabata Y (2004) Effect of culture substrates and fibroblast growth factor addition on the proliferation and differentiation of rat bone marrow stromal cells. Tissue Eng. 10, 995-1005.
23. Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M (2006) Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24, 462-471.
24. Tsutsumi S, Shimazu A, Miyazaki K, Pan H, Koike C, Yoshida E et al. (2001) Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem. Biophys. Res. Commun. 288, 413-419.
25. van den Bos C, Mosca JD, Winkles J, Kerrigan L, Burgess WH, Marshak DR (1997) Human mesenchymal stem cells respond to fibroblast growth factors. Hum. Cell 10, 45-50.
26. Maegawa N, Kawamura K, Hirose M, Yajima H, Takakura Y, Ohgushi H (2007) Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2). J. Tissue Eng. Regen. Med. 1, 306-313.
27. Solchaga LA, Penick K, Porter JD, Goldberg VM, Caplan AI, Welter JF (2005) FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J. Cell. Physiol. 203, 398-409.
28. Yip WK, Cheenpracha S, Chang LC, Ho CC, Seow HF (2010) Anti-proliferative and anti-invasive properties of a purified fraction from Streptomyces sp H7372. Int. J. Oncol. 37, 1229-1241.
29. Cárcamo-Orive I, Tejados N, Delgado J, Gaztelumendi A, Otaegui D, Lang V et al. (2008) ERK2 protein regulates the proliferation of human mesenchymal stem cells without affecting their mobilization and differentiation potential. Exp. Cell Res. 314, 1777-1788.
30. Sherr CJ (1994) G1 phase progression: cycling on cue. Cell 79, 551-555.
31. Pardee AB (1989) G1 events and regulation of cell proliferation. Science 246, 603-608.
32. Neubauer M, Hacker M, Bauer-Kreisel P, Weiser B, Fischbach C, Schulz MB et al. (2005) Adipose tissue engineering based on mesenchymal stem cells and basic fibroblast growth factor in vitro. Tissue Eng. 11, 1840-1851.
33. Zhu Y, Liu T, Song K, Fan X, Ma X, Cui Z (2008) Adipose-derived stem cell: a better stem cell than BMSC. Cell Biochem. Funct. 26, 664-675.
34. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P et al. (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99, 3838-3843.
35. Jeon ES, Heo SC, Lee IH, Choi YJ, Park JH, Choi KU et al. (2010) Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and SDF-1a from human mesenchymal stem cells. Exp. Mol. Med. 42, 280-293.